“Therapeutic Effects of Proprotein Convertase Subtilisin Kexin Type 9 Inhibitors in Dyslipidemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials”. 2025. Althea Medical Journal 12 (3): 161-71. https://doi.org/10.15850/amj.v12n3.4209.